Neuronetics Inc (NASDAQ: STIM) kicked off on Friday, up 6.72% from the previous trading day, before settling in for the closing price of $1.19. Over the past 52 weeks, STIM has traded in a range of $0.52-$5.07.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 7.39%. While this was happening, its average annual earnings per share was recorded -20.96%. With a float of $28.01 million, this company’s outstanding shares have now reached $30.32 million.
Let’s determine the extent of company efficiency that accounts for 203 employees. In terms of profitability, gross margin is 74.23%, operating margin of -37.85%, and the pretax margin is -50.09%.
Neuronetics Inc (STIM) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Neuronetics Inc is 7.69%, while institutional ownership is 34.87%. The most recent insider transaction that took place on Oct 08 ’24, was worth 1,122. In this transaction EVP, CFO and Treasurer of this company sold 1,368 shares at a rate of $0.82, taking the stock ownership to the 497,408 shares. Before that another transaction happened on Oct 08 ’24, when Company’s EVP, GC, CCO and CS sold 1,541 for $0.82, making the entire transaction worth $1,264. This insider now owns 402,792 shares in total.
Neuronetics Inc (STIM) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -20.96% per share during the next fiscal year.
Neuronetics Inc (NASDAQ: STIM) Trading Performance Indicators
Take a look at Neuronetics Inc’s (STIM) current performance indicators. Last quarter, stock had a quick ratio of 2.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.22, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.67 in one year’s time.
Technical Analysis of Neuronetics Inc (STIM)
Looking closely at Neuronetics Inc (NASDAQ: STIM), its last 5-days average volume was 0.33 million, which is a jump from its year-to-date volume of 0.3 million. As of the previous 9 days, the stock’s Stochastic %D was 93.80%. Additionally, its Average True Range was 0.13.
During the past 100 days, Neuronetics Inc’s (STIM) raw stochastic average was set at 49.67%, which indicates a significant decrease from 93.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.99% in the past 14 days, which was lower than the 183.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9408, while its 200-day Moving Average is $2.0435. However, in the short run, Neuronetics Inc’s stock first resistance to watch stands at $1.3863. Second resistance stands at $1.5027. The third major resistance level sits at $1.6953. If the price goes on to break the first support level at $1.0773, it is likely to go to the next support level at $0.8847. Now, if the price goes above the second support level, the third support stands at $0.7683.
Neuronetics Inc (NASDAQ: STIM) Key Stats
The company with the Market Capitalisation of 41.13 million has total of 30,348K Shares Outstanding. Its annual sales at the moment are 71,350 K in contrast with the sum of -30,190 K annual income. Company’s last quarter sales were recorded 18,530 K and last quarter income was -13,340 K.
